BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27904103)

  • 1. Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty.
    Daidoji H; Tamada Y; Suzuki S; Watanabe K; Shikama T; Kikuchi Y; Kato S; Takahashi K; Fukui A; Matsui M; Yahagi T; Goto T
    Intern Med; 2016; 55(23):3421-3426. PubMed ID: 27904103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?
    Iwashima Y; Ishimitsu T
    Hypertens Res; 2020 Oct; 43(10):1015-1027. PubMed ID: 32572170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of percutaneous transluminal renal angioplasty for pediatric renovascular hypertension: a meta-analysis].
    Zhao X; Zhao L; Wu L; Zhang Y; Huang GY
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):661-667. PubMed ID: 32842387
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
    Takamiya Y; Okamura K; Shirai K; Urata H
    Am J Case Rep; 2019 Nov; 20():1684-1690. PubMed ID: 31732710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature.
    Manolis AS; Manolis AA; Melita H
    Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
    Roussos L; Christensson A; Thompson O
    Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does percutaneous transluminal renal artery angioplasty improve blood pressure control and renal function in patients with atherosclerotic renal artery stenosis?
    Wolak T; Belkin A; Ginsburg V; Greenberg G; Mayzler O; Bolotin A; Paran E; Szendro G
    Isr Med Assoc J; 2011 Oct; 13(10):619-24. PubMed ID: 22097232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal angioplasty for renovascular hypertension in children: initial and long-term results.
    Tyagi S; Kaul UA; Satsangi DK; Arora R
    Pediatrics; 1997 Jan; 99(1):44-9. PubMed ID: 8989336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular therapy of renovascular hypertension in children: single center analysis.
    Radanović B; Cacić Z; Perkov D; Smiljanić R; Corić SR; Ilakovac K
    Eur J Pediatr Surg; 2009 Jun; 19(3):135-40. PubMed ID: 19360546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis.
    Yoshihara F; Fukuda T; Iwashima Y; Nakamura S; Hayashi S; Kishida M; Ishizuka A; Kusunoki H; Ohta Y; Kawano Y
    Clin Exp Hypertens; 2015; 37(7):526-30. PubMed ID: 25919953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of renal artery revascularization in the post-ASTRAL era with 4 years mean follow-up.
    Zachrisson K; Krupic F; Svensson M; Wigelius A; Jonsson A; Dimopoulou A; Stenborg A; Jensen G; Herlitz H; Gottsäter A; Falkenberg M
    Blood Press; 2020 Oct; 29(5):285-290. PubMed ID: 32363961
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial measurements of plasma renin activity, aldosterone and cortisol during percutaneous transluminal angioplasty of the renal artery in man.
    Hägg A; Lörelius LE; Mörlin C; Wide L
    Acta Physiol Scand; 1988 Dec; 134(4):473-8. PubMed ID: 2977883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course of the changes in blood pressure and in plasma renin activity during the first week after dilation of renal artery stenosis.
    Morganti A; Quorso P; Ferraris P; Lovaria A; Fruscio M; Saccheri S; Zanchetti A
    J Hypertens Suppl; 1989 Dec; 7(6):S186-7. PubMed ID: 2534402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with percutaneous transluminal renal angioplasty in renovascular hypertension.
    Pedersen EB; Madsen B; Danielsen H; Jespersen B
    Acta Med Scand Suppl; 1986; 714():23-7. PubMed ID: 2953176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous recording of muscle nerve sympathetic activity during percutaneous transluminal angioplasty in renovascular hypertension in man.
    Mörlin C; Fagius J; Hägg A; Lörelius LE; Niklasson F
    J Hypertens; 1990 Mar; 8(3):239-44. PubMed ID: 2159504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularisation in renovascular disease--a retrospective comparison of results, complications, and mortality.
    Alhadad A; Ahle M; Ivancev K; Gottsäter A; Lindblad B
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):151-6. PubMed ID: 14718896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioplasty of the renal artery: antihypertensive and renal effects.
    Morganti A
    J Nephrol; 2000; 13 Suppl 3():S28-33. PubMed ID: 11132030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal renal angioplasty in the treatment of renovascular hypertension in children.
    Fallo F; Oberfield SE; Levine LS; Stoner E; Greig F; Sniderman K; Saddekni S; Sos T; New MI
    Clin Exp Hypertens A; 1986; 8(4-5):887-91. PubMed ID: 2944677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transluminal renal angioplasty attenuates poststenotic kidney mitochondrial damage in pigs with renal artery stenosis and metabolic syndrome.
    Farahani RA; Afarideh M; Zhu XY; Tang H; Jordan KL; Saadiq IM; Ferguson CM; Lerman A; Textor SC; Lerman LO; Eirin A
    J Cell Physiol; 2021 May; 236(5):4036-4049. PubMed ID: 33151557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.